Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Isaac Teitelbaum

Concepts (359)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
60
2025
100
15.380
 Why?
Kidney Failure, Chronic
45
2025
599
8.460
 Why?
Peritonitis
24
2025
83
4.670
 Why?
Dialysis Solutions
12
2025
23
2.570
 Why?
Renal Dialysis
18
2022
466
2.250
 Why?
Hyponatremia
3
2025
43
1.780
 Why?
Sodium
4
2025
198
1.760
 Why?
Glucans
3
2025
22
1.360
 Why?
Peritoneum
6
2023
43
1.090
 Why?
Kidney
8
2023
1494
1.070
 Why?
Glucose
3
2025
1048
0.940
 Why?
Serum Albumin
3
2022
146
0.830
 Why?
Kidney Tubules, Collecting
12
1994
27
0.830
 Why?
Catheter-Related Infections
2
2025
96
0.770
 Why?
Peritoneal Dialysis, Continuous Ambulatory
7
2025
16
0.740
 Why?
Catheters, Indwelling
6
2025
96
0.720
 Why?
Staphylococcus capitis
1
2019
1
0.620
 Why?
Acute Kidney Injury
5
2023
872
0.620
 Why?
Coagulase
1
2019
6
0.620
 Why?
Renal Insufficiency, Chronic
3
2015
661
0.580
 Why?
Renal Replacement Therapy
4
2023
100
0.580
 Why?
Ferric Compounds
2
2022
54
0.570
 Why?
Sucrose
2
2022
114
0.560
 Why?
Quality of Health Care
2
2020
692
0.560
 Why?
Humans
82
2025
145140
0.550
 Why?
Arginine Vasopressin
7
1997
44
0.530
 Why?
Hyperphosphatemia
3
2022
15
0.530
 Why?
Kidney Transplantation
3
2012
710
0.520
 Why?
Staphylococcal Infections
3
2019
390
0.510
 Why?
Anti-Bacterial Agents
6
2024
1922
0.510
 Why?
Peritoneal Fibrosis
1
2017
2
0.510
 Why?
Kidney Function Tests
4
2020
156
0.490
 Why?
Uremia
2
2014
15
0.480
 Why?
Patient-Centered Care
1
2020
547
0.450
 Why?
Therapeutics
1
2015
14
0.440
 Why?
Kidney Medulla
10
1997
31
0.440
 Why?
Body Water
1
2015
23
0.440
 Why?
Voriconazole
1
2015
21
0.440
 Why?
beta-Cyclodextrins
1
2015
32
0.430
 Why?
Phosphates
2
2022
177
0.420
 Why?
Catheterization
3
2016
183
0.420
 Why?
Antifungal Agents
1
2015
150
0.410
 Why?
Chelating Agents
1
2014
76
0.390
 Why?
Blood Pressure
1
2020
1778
0.390
 Why?
GTP-Binding Proteins
6
1995
153
0.370
 Why?
Type C Phospholipases
6
1992
69
0.370
 Why?
Hemodialysis Solutions
1
2012
3
0.370
 Why?
Acidosis
1
2013
105
0.350
 Why?
Kidney Diseases
4
2021
424
0.340
 Why?
Hemofiltration
2
2010
24
0.340
 Why?
Hirudins
1
2010
53
0.320
 Why?
Practice Patterns, Physicians'
3
2025
1365
0.320
 Why?
Cyclic AMP
6
1995
207
0.300
 Why?
Urea
4
2021
85
0.300
 Why?
Creatinine
5
2020
513
0.300
 Why?
Middle Aged
21
2025
36126
0.290
 Why?
Protein Kinase C
5
1995
251
0.290
 Why?
Heparin
1
2010
246
0.290
 Why?
Kidney Tubules
4
1990
118
0.290
 Why?
Nutritional Status
4
2022
353
0.280
 Why?
Heart Diseases
1
2012
341
0.280
 Why?
Infection Control
2
2025
173
0.270
 Why?
Glomerular Filtration Rate
5
2023
765
0.270
 Why?
Drug Resistance, Bacterial
1
2009
185
0.270
 Why?
Hemodialysis, Home
4
2023
9
0.260
 Why?
Peptide Fragments
1
2010
693
0.250
 Why?
Survivors
1
2010
522
0.240
 Why?
Prospective Studies
12
2025
8035
0.240
 Why?
Scleroderma, Systemic
1
2007
123
0.230
 Why?
Calcium
4
2020
1189
0.230
 Why?
Cardiac Surgical Procedures
1
2012
608
0.230
 Why?
Patient Selection
2
2020
733
0.230
 Why?
Hernia, Abdominal
1
2005
7
0.230
 Why?
Peritoneal Cavity
1
2005
30
0.230
 Why?
Patient Participation
2
2020
437
0.220
 Why?
Phosphorus
3
2022
90
0.220
 Why?
Postoperative Complications
3
2012
2961
0.210
 Why?
Female
25
2025
78636
0.210
 Why?
Liver Failure
1
2005
83
0.210
 Why?
Liver Transplantation
2
2012
826
0.210
 Why?
Aged
15
2025
26096
0.210
 Why?
Internationality
3
2020
156
0.210
 Why?
Time Factors
6
2015
7107
0.210
 Why?
Hemoglobins
2
2020
386
0.210
 Why?
Teicoplanin
1
2024
14
0.200
 Why?
Male
25
2025
72664
0.200
 Why?
Dose-Response Relationship, Drug
3
2025
2026
0.190
 Why?
Quality Improvement
2
2023
1293
0.190
 Why?
Blood Chemical Analysis
1
2003
109
0.190
 Why?
Practice Guidelines as Topic
3
2020
1579
0.180
 Why?
Quality of Life
5
2020
3194
0.180
 Why?
Device Removal
2
2019
142
0.180
 Why?
Phosphatidylinositols
3
1991
57
0.180
 Why?
Rats
13
2014
5582
0.180
 Why?
Risk Factors
8
2025
10857
0.180
 Why?
Contraindications, Procedure
1
2021
13
0.180
 Why?
Treatment Outcome
10
2025
11741
0.170
 Why?
Goals
2
2020
184
0.170
 Why?
Nephrologists
1
2021
14
0.170
 Why?
Attitude of Health Personnel
2
2020
1186
0.170
 Why?
Patient Education as Topic
4
2025
775
0.170
 Why?
Organism Hydration Status
1
2020
9
0.170
 Why?
Superior Vena Cava Syndrome
1
2000
4
0.160
 Why?
Chylous Ascites
1
2000
5
0.160
 Why?
Epidermal Growth Factor
6
1994
161
0.160
 Why?
Liver Cirrhosis
1
2003
287
0.160
 Why?
Liposomes
1
2022
259
0.160
 Why?
Acid-Base Equilibrium
1
2020
23
0.160
 Why?
Critical Illness
4
2023
899
0.160
 Why?
Stress, Psychological
1
2009
1145
0.160
 Why?
Blood Volume
1
2020
65
0.160
 Why?
Magnesium
1
2020
156
0.150
 Why?
Potassium
1
2020
152
0.150
 Why?
Cohort Studies
5
2025
5988
0.150
 Why?
Patient Care Planning
1
2020
170
0.150
 Why?
Physician Executives
1
2019
30
0.150
 Why?
Patient Reported Outcome Measures
2
2020
497
0.140
 Why?
Congresses as Topic
1
2020
223
0.140
 Why?
Dogs
2
2023
438
0.130
 Why?
Receptors, Vasopressin
2
1995
20
0.130
 Why?
Societies, Medical
2
2020
898
0.130
 Why?
Kidney Concentrating Ability
1
1997
3
0.130
 Why?
Drug Combinations
2
2022
396
0.130
 Why?
Survival Rate
2
2020
2087
0.130
 Why?
Renal Insufficiency
1
2020
172
0.130
 Why?
Data Collection
1
2020
639
0.130
 Why?
Adenylyl Cyclase Inhibitors
2
1994
7
0.130
 Why?
Adenylyl Cyclases
3
1993
60
0.130
 Why?
Risk Assessment
4
2016
3740
0.130
 Why?
Adult
18
2024
40665
0.120
 Why?
United States
7
2023
16065
0.120
 Why?
Antibiotic Prophylaxis
3
2025
134
0.120
 Why?
Proportional Hazards Models
3
2022
1325
0.120
 Why?
Survival Analysis
2
2015
1371
0.120
 Why?
Hormones
2
1994
135
0.110
 Why?
Models, Animal
1
2017
393
0.110
 Why?
Ultrafiltration
1
2015
28
0.110
 Why?
Epithelial-Mesenchymal Transition
1
2017
219
0.110
 Why?
Kaplan-Meier Estimate
2
2015
968
0.100
 Why?
Gastrointestinal Absorption
1
2014
5
0.100
 Why?
Curriculum
1
2021
1067
0.100
 Why?
Diglycerides
2
1993
61
0.100
 Why?
Virulence Factors, Bordetella
2
1991
15
0.100
 Why?
Treatment Failure
1
2015
360
0.100
 Why?
Lung Injury
1
2017
241
0.100
 Why?
Pertussis Toxin
2
1991
24
0.100
 Why?
Phospholipases A
2
1992
97
0.100
 Why?
Didanosine
1
1993
13
0.100
 Why?
Biological Transport
1
2015
423
0.100
 Why?
Anti-Infective Agents
1
2016
232
0.100
 Why?
Inflammation
3
2017
2876
0.100
 Why?
Cytosol
1
1994
212
0.100
 Why?
Animals
17
2023
37952
0.100
 Why?
Biomedical Research
1
2020
717
0.100
 Why?
HIV Seropositivity
1
1993
119
0.090
 Why?
Oleanolic Acid
1
2012
9
0.090
 Why?
Methylene Blue
1
2012
24
0.090
 Why?
Equipment Design
2
2014
525
0.090
 Why?
Vascular Calcification
1
2014
110
0.090
 Why?
Tissue Adhesions
1
2012
34
0.090
 Why?
Palliative Care
1
2020
1017
0.090
 Why?
Delayed Graft Function
1
2012
46
0.090
 Why?
Hematinics
1
2012
22
0.090
 Why?
Cells, Cultured
9
1994
4142
0.090
 Why?
Prognosis
4
2016
4310
0.090
 Why?
Receptors, Angiotensin
1
1991
11
0.090
 Why?
Nephrectomy
1
2012
161
0.090
 Why?
Vasoconstrictor Agents
1
2012
150
0.080
 Why?
Transplantation, Homologous
1
2012
417
0.080
 Why?
Atrial Natriuretic Factor
1
1991
55
0.080
 Why?
Bacterial Infections
2
2003
246
0.080
 Why?
Hypotension
1
2012
127
0.080
 Why?
Restless Legs Syndrome
1
2011
20
0.080
 Why?
Retrospective Studies
6
2023
17247
0.080
 Why?
Glycerides
1
1990
16
0.080
 Why?
Aluminum Compounds
1
1990
6
0.080
 Why?
Phospholipases
1
1990
14
0.080
 Why?
Antithrombins
1
2010
71
0.080
 Why?
Membranes, Artificial
1
2010
68
0.080
 Why?
Virginiamycin
1
2009
3
0.080
 Why?
Graft Survival
1
2012
517
0.070
 Why?
Models, Biological
1
2017
1763
0.070
 Why?
Follow-Up Studies
4
2011
5411
0.070
 Why?
Daptomycin
1
2009
18
0.070
 Why?
Oxazolidinones
1
2009
17
0.070
 Why?
Linezolid
1
2009
25
0.070
 Why?
Double-Blind Method
2
2012
2057
0.070
 Why?
Protein Kinases
1
1991
312
0.070
 Why?
Minerals
1
2009
48
0.070
 Why?
Acetamides
1
2009
39
0.070
 Why?
Enzyme Inhibitors
1
2012
820
0.070
 Why?
Hematuria
1
1988
11
0.070
 Why?
Enzyme Activation
4
1994
762
0.070
 Why?
Sympathetic Nervous System
1
1989
181
0.070
 Why?
Communicable Diseases
1
2010
166
0.070
 Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
 Why?
Proteinuria
1
1988
104
0.070
 Why?
Hepatorenal Syndrome
1
2007
15
0.070
 Why?
Tetradecanoylphorbol Acetate
3
1993
149
0.060
 Why?
Spondylitis, Ankylosing
1
1988
43
0.060
 Why?
Recombinant Proteins
1
2010
1368
0.060
 Why?
RNA, Messenger
1
1995
2803
0.060
 Why?
Aged, 80 and over
1
2019
8318
0.060
 Why?
Sleep Wake Disorders
1
2011
310
0.060
 Why?
Inositol Phosphates
3
1991
21
0.060
 Why?
Primary Prevention
2
2016
218
0.060
 Why?
ErbB Receptors
1
1990
635
0.060
 Why?
Biopsy, Needle
1
2007
185
0.060
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
 Why?
Nephrology
2
2020
60
0.060
 Why?
Imipenem
1
2005
16
0.060
 Why?
Incidence
3
2007
2915
0.060
 Why?
Kinetics
3
2017
1567
0.060
 Why?
Ethics, Clinical
1
2005
9
0.060
 Why?
Skin Diseases
1
2007
152
0.050
 Why?
Anticoagulants
1
2010
748
0.050
 Why?
Vasculitis
1
2005
69
0.050
 Why?
Staphylococcus aureus
1
2009
451
0.050
 Why?
Medication Adherence
1
2009
540
0.050
 Why?
Capillaries
1
2005
125
0.050
 Why?
Fibrosis
1
2007
554
0.050
 Why?
Gastric Acid
1
2023
12
0.050
 Why?
Canada
1
2005
429
0.050
 Why?
Bromcresol Green
1
2003
1
0.050
 Why?
Bromcresol Purple
1
2003
1
0.050
 Why?
Nephelometry and Turbidimetry
1
2003
15
0.050
 Why?
Hepcidins
1
2023
21
0.050
 Why?
Combined Modality Therapy
1
2007
1264
0.050
 Why?
Indicators and Reagents
1
2003
106
0.050
 Why?
Triglycerides
1
2006
520
0.050
 Why?
Drug Resistance
2
2012
145
0.050
 Why?
Permeability
1
2003
169
0.050
 Why?
Eosinophils
1
2006
316
0.050
 Why?
Equipment Failure
1
2003
115
0.050
 Why?
Vancomycin
1
2024
94
0.050
 Why?
Disease Models, Animal
1
2014
4552
0.050
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
20
0.050
 Why?
Monocytes
1
2006
537
0.050
 Why?
Health Services Accessibility
1
2011
1099
0.050
 Why?
Severity of Illness Index
2
2011
2928
0.050
 Why?
Regression Analysis
1
2005
998
0.050
 Why?
Hypoalbuminemia
1
2022
27
0.050
 Why?
Cats
1
2023
228
0.050
 Why?
Lung Transplantation
1
2005
329
0.040
 Why?
Medicare
2
2022
902
0.040
 Why?
Burns
1
2007
374
0.040
 Why?
Phospholipases A2
2
1992
79
0.040
 Why?
Ownership
1
2023
115
0.040
 Why?
Patient Compliance
1
2006
587
0.040
 Why?
Positron-Emission Tomography
1
2023
343
0.040
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
15
0.040
 Why?
Guanosine Diphosphate
2
1991
20
0.040
 Why?
Thionucleotides
2
1991
35
0.040
 Why?
Erythrocytes
1
2006
747
0.040
 Why?
Dinoprostone
2
1990
180
0.040
 Why?
Recurrence
1
2003
1134
0.040
 Why?
Chronic Disease
1
2005
1806
0.040
 Why?
Child
3
2013
22670
0.040
 Why?
Potassium, Dietary
1
1998
12
0.030
 Why?
Drinking
1
1998
44
0.030
 Why?
Terminology as Topic
1
2020
256
0.030
 Why?
Sodium, Dietary
1
1998
42
0.030
 Why?
Predictive Value of Tests
2
2017
2115
0.030
 Why?
Cardiovascular Diseases
1
2010
2183
0.030
 Why?
Diabetes Mellitus, Type 2
1
2012
2578
0.030
 Why?
Quality Control
1
2017
161
0.030
 Why?
Diabetic Nephropathies
1
2000
319
0.030
 Why?
Pilot Projects
1
2022
1889
0.030
 Why?
Fluid Therapy
1
2017
154
0.030
 Why?
Reproducibility of Results
1
2003
3410
0.030
 Why?
Prostaglandins
1
1995
94
0.030
 Why?
Hospitalization
1
2006
2458
0.030
 Why?
Ionomycin
1
1994
22
0.030
 Why?
Quality Indicators, Health Care
1
2017
336
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
165
0.030
 Why?
Isoproterenol
1
1994
96
0.030
 Why?
Colforsin
1
1993
47
0.020
 Why?
Prevalence
2
2011
2855
0.020
 Why?
Guanylate Cyclase
1
1992
38
0.020
 Why?
Interleukin-6
1
2017
775
0.020
 Why?
Shock, Surgical
1
2012
2
0.020
 Why?
Catecholamines
1
2012
88
0.020
 Why?
Sample Size
1
2012
121
0.020
 Why?
Intraoperative Care
1
2012
63
0.020
 Why?
Poisson Distribution
1
2012
78
0.020
 Why?
Prospective Payment System
1
2011
15
0.020
 Why?
Base Sequence
1
1995
2168
0.020
 Why?
Total Quality Management
1
2011
57
0.020
 Why?
Inositol
1
1991
25
0.020
 Why?
Receptors, Oxytocin
1
1991
20
0.020
 Why?
Accreditation
1
2011
101
0.020
 Why?
Cyclic GMP
1
1991
90
0.020
 Why?
Dideoxyadenosine
1
1990
3
0.020
 Why?
Molecular Sequence Data
1
1995
2881
0.020
 Why?
Oxytocin
1
1991
51
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
28
0.020
 Why?
Isoquinolines
1
1990
43
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
5
0.020
 Why?
Fluorides
1
1990
49
0.020
 Why?
Guanosine Triphosphate
1
1990
89
0.020
 Why?
Aluminum
1
1990
43
0.020
 Why?
Hydrolysis
1
1990
197
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2524
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
28
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
34
0.020
 Why?
Analysis of Variance
1
2012
1300
0.020
 Why?
Health Surveys
1
2011
517
0.020
 Why?
Rats, Inbred Strains
1
1989
321
0.020
 Why?
Adrenergic beta-Agonists
1
1989
92
0.020
 Why?
In Vitro Techniques
1
1990
1048
0.020
 Why?
Glomerulonephritis, IGA
1
1988
12
0.020
 Why?
Piperazines
1
1990
375
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
252
0.020
 Why?
Clinical Trials as Topic
1
2012
1058
0.020
 Why?
Cost of Illness
1
2009
324
0.020
 Why?
Morbidity
1
2007
322
0.010
 Why?
Research Design
1
2012
1132
0.010
 Why?
Cilastatin
1
2005
2
0.010
 Why?
Hemodiafiltration
1
2005
7
0.010
 Why?
Biomarkers
1
2017
4282
0.010
 Why?
Drug Monitoring
1
2009
399
0.010
 Why?
Multivariate Analysis
1
2009
1546
0.010
 Why?
Osmolar Concentration
2
1998
168
0.010
 Why?
Healthcare Disparities
1
2012
731
0.010
 Why?
Protease Inhibitors
1
2005
102
0.010
 Why?
Biopsy
1
1988
1079
0.010
 Why?
Telemedicine
1
2014
956
0.010
 Why?
Sensitivity and Specificity
1
2009
1995
0.010
 Why?
Comorbidity
1
2009
1657
0.010
 Why?
Acute Disease
1
2007
1035
0.010
 Why?
Protein Kinase Inhibitors
1
1990
979
0.010
 Why?
Respiratory Function Tests
1
2005
543
0.010
 Why?
Drug Therapy, Combination
1
2005
1043
0.010
 Why?
Graft Rejection
1
2005
518
0.010
 Why?
Immunosuppressive Agents
1
2005
837
0.010
 Why?
Colorado
1
1990
4538
0.010
 Why?
Mice
1
2017
18303
0.010
 Why?
Lung Diseases
1
2005
780
0.010
 Why?
Diet, Vegetarian
1
1998
10
0.010
 Why?
Beer
1
1998
13
0.010
 Why?
Urine
1
1998
64
0.010
 Why?
Cross-Sectional Studies
1
2009
5886
0.010
 Why?
Dietary Proteins
1
1998
135
0.010
 Why?
Signal Transduction
1
1990
5208
0.010
 Why?
Muscarine
1
1994
3
0.010
 Why?
Carbachol
1
1994
17
0.010
 Why?
Vasopressins
1
1994
61
0.010
 Why?
Tyrosine
1
1994
217
0.010
 Why?
Cell Polarity
1
1994
137
0.010
 Why?
Purines
1
1994
186
0.010
 Why?
Adolescent
1
2012
22479
0.010
 Why?
Lung
1
2005
4101
0.010
 Why?
Hypertonic Solutions
1
1991
7
0.010
 Why?
Nocodazole
1
1991
17
0.010
 Why?
Cycloheximide
1
1991
42
0.010
 Why?
Isotonic Solutions
1
1991
42
0.010
 Why?
Culture Media
1
1991
161
0.010
 Why?
Phosphorylation
1
1994
1706
0.000
 Why?
Peptides
1
1994
997
0.000
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (359) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)